Barclays maintained an “Overweight” rating on PDD Holdings Inc. (NASDAQ:PDD) and kept a price target of $158. This decision ...

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

JPMorgan analysts increased the price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) stock to $500 from $450 and ...

Piper Sandler lifted the price target on NVIDIA Corporation (NASDAQ:NVDA) stock from $150 to $180, reaffirming its Overweight ...

According to InvestingPro data, analysts maintain a strong buy consensus ... JPMorgan maintained its Overweight rating for ORIC Pharmaceuticals with a $20 price target, highlighting the potential ...

Enrollment in a patient-delivered intervention allowed adults with overweight or obesity to better maintain weight loss than ...

On Wednesday, Cantor Fitzgerald reaffirmed its confidence in Surgery Partners (NASDAQ:SGRY), maintaining an Overweight stock rating with a steady price target of $36.00. Currently trading at $23. ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Nifty 50 is currently trading at 20.2 times one-year forward price-to-earnings ratio (PER), slightly below its five-year ...

Attrition rates in IT Services may not rise further, while other growth drivers may persist. The brokerage lowered estimates ...

Nutanix, Inc. (NASDAQ:NTNX) received a vote of confidence from Piper Sandler on May 29, as the firm raised its price target ...